Novo Nordisk Haemophilia Foundation (NNHF)

Together delivering life-changing action

With proper diagnosis and care haemophilia and allied bleeding disorders are treatable. People can lead normal lives and have a near-normal life expectancy. This is however not the situation everywhere, particularly in the developing world, where 75% of the global patient population lives, many patients remain undiagnosed or do not receive adequate care and treatment.

Improving access to care

10 years of creating local impact together

For 10 years we have worked together with our local partners to define and fund sustainable programmes which improve access to care benefitting people with haemophilia and allied bleeding disorders in the developing world.

In collaboration with internationally renowned experts, the NNHF addresses three focus areas which guide every initiative; capacity building, diagnosis and registry as well as disease education and raising awareness.
 
Download our infographic for a snapshot of the impact created by NNHF in 10 years.

NNHF development programmes


Learn more about the NNHF programmes

The NNHF currently funds three types of development programmes: development projects tailored to local needs, fellowships and awards. To date, the NNHF supports programmes in 63 countries across the world.

For detailed information on NNHF programmes including how to apply for funding, please visit www.nnhf.org.  For quarterly updates on NNHF’s programmes, sign up for the NNHF newsletter.

  •  
Read about Haemophilia
  •  
  •  
NNHF - Striving to increase haemophilia awareness and expertise
  •